JP2019529487A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529487A5 JP2019529487A5 JP2019517027A JP2019517027A JP2019529487A5 JP 2019529487 A5 JP2019529487 A5 JP 2019529487A5 JP 2019517027 A JP2019517027 A JP 2019517027A JP 2019517027 A JP2019517027 A JP 2019517027A JP 2019529487 A5 JP2019529487 A5 JP 2019529487A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- cooh
- appearance
- coor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662401762P | 2016-09-29 | 2016-09-29 | |
| US62/401,762 | 2016-09-29 | ||
| PCT/US2017/054053 WO2018064356A1 (en) | 2016-09-29 | 2017-09-28 | Compounds and methods for treating lupus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019529487A JP2019529487A (ja) | 2019-10-17 |
| JP2019529487A5 true JP2019529487A5 (https=) | 2020-09-10 |
| JP7086945B2 JP7086945B2 (ja) | 2022-06-20 |
Family
ID=60043386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517027A Active JP7086945B2 (ja) | 2016-09-29 | 2017-09-28 | 狼瘡を処置するための化合物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11278526B2 (https=) |
| EP (1) | EP3518922B1 (https=) |
| JP (1) | JP7086945B2 (https=) |
| KR (1) | KR102408814B1 (https=) |
| CA (1) | CA3038106A1 (https=) |
| WO (1) | WO2018064356A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3630738B1 (en) * | 2017-05-22 | 2023-07-19 | Egis Gyógyszergyár Zrt. | Process for the production of ozanimod |
| AR116479A1 (es) * | 2018-09-25 | 2021-05-12 | Quim Sintetica S A | Intermediarios para la síntesis de ozanimod y procedimiento para la preparación del mencionado agonista del receptor de esfingosina-1-fosfato y de dichos intermediarios |
| EP3947363A4 (en) * | 2019-03-29 | 2023-01-04 | Receptos Llc | SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATORS |
| CN116332794B (zh) * | 2021-12-24 | 2024-10-15 | 上海合全药物研发有限公司 | 一种芳基腈类化合物的制备方法 |
| US12565492B2 (en) | 2024-08-09 | 2026-03-03 | Triana Biomedicines, Inc. | Anaplastic Lymphoma Kinase (ALK) degraders and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0612028A2 (pt) | 2005-06-08 | 2010-10-13 | Novartis Ag | oxadiazóis ou isodiazóis policìclicos e uso dos mesmos como ligantes de receptor s1p |
| RU2009115963A (ru) | 2006-09-29 | 2010-11-10 | Новартис АГ (CH) | Производные оксадиазола, обладающие противовоспалительными и иммунодепрессантными свойствами |
| JO2701B1 (en) | 2006-12-21 | 2013-03-03 | جلاكسو جروب ليميتد | Vehicles |
| SI2291080T1 (sl) | 2008-05-14 | 2015-11-30 | The Scripps Research Institute | Novi modulatorji sfingosinskih fosfatnih receptorjev |
| EA024801B1 (ru) * | 2009-11-13 | 2016-10-31 | Рецептос Ллк | Селективные модуляторы рецептора сфингозин-1-фосфата |
| US20170165236A1 (en) * | 2013-11-01 | 2017-06-15 | Celgene International Ii Sàrl | Selective sphingosine 1 phosphate receptor modulators and combination therapy therewith |
-
2017
- 2017-09-28 KR KR1020197011411A patent/KR102408814B1/ko active Active
- 2017-09-28 WO PCT/US2017/054053 patent/WO2018064356A1/en not_active Ceased
- 2017-09-28 EP EP17781337.5A patent/EP3518922B1/en active Active
- 2017-09-28 CA CA3038106A patent/CA3038106A1/en active Pending
- 2017-09-28 JP JP2019517027A patent/JP7086945B2/ja active Active
- 2017-09-28 US US16/337,292 patent/US11278526B2/en active Active